医学
乳腺癌
优势比
前瞻性队列研究
癌症
结直肠癌
队列研究
逻辑回归
外科
内科学
作者
Stephen R Knight,Caitlin Shaw,Riinu Pius,Thomas M Drake,Lisa Norman,Adesoji Ademuyiwa,Adewale Adisa,María Lorena Aguilera,Sara W Al‐Saqqa,Ibrahim Al‐Slaibi,Aneel Bhangu,Bruce Biccard,Peter Brocklehurst,Ainhoa Costas‐Chavarri,Kathryn Chu,Anna Dare,Muhammed Elhadi,Cameron J Fairfield,J.E.F. Fitzgerald,Dhruva Ghosh
出处
期刊:The Lancet
[Elsevier BV]
日期:2021-01-01
卷期号:397 (10272): 387-397
被引量:216
标识
DOI:10.1016/s0140-6736(21)00001-5
摘要
Background80% of individuals with cancer will require a surgical procedure, yet little comparative data exist on early outcomes in low-income and middle-income countries (LMICs). We compared postoperative outcomes in breast, colorectal, and gastric cancer surgery in hospitals worldwide, focusing on the effect of disease stage and complications on postoperative mortality.MethodsThis was a multicentre, international prospective cohort study of consecutive adult patients undergoing surgery for primary breast, colorectal, or gastric cancer requiring a skin incision done under general or neuraxial anaesthesia. The primary outcome was death or major complication within 30 days of surgery. Multilevel logistic regression determined relationships within three-level nested models of patients within hospitals and countries. Hospital-level infrastructure effects were explored with three-way mediation analyses. This study was registered with ClinicalTrials.gov, NCT03471494.FindingsBetween April 1, 2018, and Jan 31, 2019, we enrolled 15 958 patients from 428 hospitals in 82 countries (high income 9106 patients, 31 countries; upper-middle income 2721 patients, 23 countries; or lower-middle income 4131 patients, 28 countries). Patients in LMICs presented with more advanced disease compared with patients in high-income countries. 30-day mortality was higher for gastric cancer in low-income or lower-middle-income countries (adjusted odds ratio 3·72, 95% CI 1·70–8·16) and for colorectal cancer in low-income or lower-middle-income countries (4·59, 2·39–8·80) and upper-middle-income countries (2·06, 1·11–3·83). No difference in 30-day mortality was seen in breast cancer. The proportion of patients who died after a major complication was greatest in low-income or lower-middle-income countries (6·15, 3·26–11·59) and upper-middle-income countries (3·89, 2·08–7·29). Postoperative death after complications was partly explained by patient factors (60%) and partly by hospital or country (40%). The absence of consistently available postoperative care facilities was associated with seven to 10 more deaths per 100 major complications in LMICs. Cancer stage alone explained little of the early variation in mortality or postoperative complications.InterpretationHigher levels of mortality after cancer surgery in LMICs was not fully explained by later presentation of disease. The capacity to rescue patients from surgical complications is a tangible opportunity for meaningful intervention. Early death after cancer surgery might be reduced by policies focusing on strengthening perioperative care systems to detect and intervene in common complications.FundingNational Institute for Health Research Global Health Research Unit.
科研通智能强力驱动
Strongly Powered by AbleSci AI